Keith Lorimer

Title: Keith Lorimer: Innovator in Pyrimidine Cyclohexyl Glucocorticoid Receptor Modulators

Introduction

Keith Lorimer is a notable inventor based in West Sussex, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of glucocorticoid receptor modulators. With a total of 3 patents to his name, Lorimer's work is recognized for its innovative approach to drug formulation.

Latest Patents

Among his latest patents, Lorimer has developed polymorphs of pyrimidine cyclohexyl glucocorticoid receptor modulators. The present invention provides crystalline forms of (E)-6-(4-Phenylcyclohexyl)-5-(3-trifluoromethylbenzyl)-1H-pyrimidine-2,4-dione, along with methods of making and using these compounds. This advancement holds promise for enhancing the efficacy and safety of glucocorticoid therapies.

Career Highlights

Lorimer is currently associated with Corcept Therapeutics Incorporated, where he continues to push the boundaries of pharmaceutical innovation. His work has been instrumental in advancing the understanding and application of glucocorticoid receptor modulators in clinical settings.

Collaborations

Throughout his career, Lorimer has collaborated with talented professionals, including Hazel Joan Hunt and Lorraine Donaghy. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Keith Lorimer's contributions to the field of pharmaceuticals, particularly through his innovative patents, underscore his role as a leading inventor in the industry. His work continues to impact the development of effective therapeutic solutions.